For the pharmaceutical industry, it is essential to listen and understand the feedback that their current and potential patients communicate through all sorts of channels and touchpoints.
Although there is a protocol that requires any identified Adverse Drug Reactions (ADRs) to be disclosed to the authorities, only 5–20% of them are reported. Fortunately, discussions regarding drugs, symptoms, conditions, and diseases can be analyzed to learn more about said branches of pharmaceutics. Artificial Intelligence significantly contributes in monitoring adverse episodes and understanding their impact in every phase of development.
Patient narratives of medicines and their adverse effects on social media represent an extra data source for drug safety monitoring.
At MeaningCloud, we have developed a platform to automate the process of monitoring ADRs on social media.